citalopram has been researched along with pipamperone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Buntinx, E; Crawford, GM; Haazen, L; McConnachie, A; Nemeroff, CB; Schatzberg, AF; Schlaepfer, T; Wade, AG | 1 |
1 trial(s) available for citalopram and pipamperone
| Article | Year |
|---|---|
Citalopram plus low-dose pipamperone versus citalopram plus placebo in patients with major depressive disorder: an 8-week, double-blind, randomized study on magnitude and timing of clinical response.
Topics: Adolescent; Adult; Aged; Butyrophenones; Citalopram; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Scotland; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Treatment Outcome; Young Adult | 2011 |
1 other study(ies) available for citalopram and pipamperone
| Article | Year |
|---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |